Zoledronic Acid and Clinical Fractures and Mortality after Hip Fracture

An annual infusion of zoledronic acid within 90 days after repair of a low-trauma hip fracture was associated with a reduction in the rate of new clinical fractures and with improved survival. (ClinicalTrials.gov number, NCT00046254 ClinicalTrials.gov.).